---
title: "000952.SZ (000952.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000952.SZ/news.md"
symbol: "000952.SZ"
name: "000952.SZ"
parent: "https://longbridge.com/en/quote/000952.SZ.md"
datetime: "2026-05-20T13:51:48.013Z"
locales:
  - [en](https://longbridge.com/en/quote/000952.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000952.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000952.SZ/news.md)
---

# 000952.SZ (000952.SZ) — Related News

### [](https://longbridge.com/en/news/284158551.md)
*2026-04-27T05:54:07.000Z*
> A-share pharmaceutical stocks showed volatile strength; Guangji Pharma hit the limit-up in the afternoon, while Fushine,

### [GUANGJI PHARMA released its first-quarter performance, with a net loss attributable to the parent company of 31.6436 million yuan](https://longbridge.com/en/news/284030894.md)
*2026-04-24T15:44:07.000Z*
> GUANGJI PHARMA released its first quarter report for 2026, with operating revenue of 163 million yuan, a year-on-year in

### [The "Raw Materials + Formulations" collaborative pattern is accelerating, and GUANGJI PHARMA's revenue in the first quarter increased by 9.84% year-on-year](https://longbridge.com/en/news/284018367.md)
*2026-04-24T14:07:57.000Z*
> On the evening of April 24th, GUANGJI PHARMA (000952) released its performance report, achieving an operating income of 

### [GUANGJI PHARMA: Net loss of 404 million yuan in 2025](https://longbridge.com/en/news/283982789.md)
*2026-04-24T10:37:46.000Z*
> GUANGJI PHARMA announced that the operating revenue in 2025 is expected to be 624 million yuan, a year-on-year decrease 

### [With continuous support from state-owned assets, does GUANGJI PHARMA still fear not being able to overcome the industry's winter?](https://longbridge.com/en/news/276051115.md)
*2026-02-16T10:38:02.000Z*
> This private placement fundraising plan is a rational choice for the company to combine its actual development and respo

### [Healthcare Industry Daily (02.14): Healthcare Industry Trends](https://longbridge.com/en/news/275986105.md)
*2026-02-14T19:12:16.000Z*
> The Medical Health Industry Daily (02.14) summarized several important developments: Wenzhou Bayer Dental Hospital will 

### [GUANGJI PHARMA has obtained the drug registration certificate for Mecobalamin tablets](https://longbridge.com/en/news/275719689.md)
*2026-02-12T07:58:07.000Z*
> GUANGJI PHARMA recently obtained the "Drug Registration Certificate" for Mecobalamin Tablets approved by the National Me